- Home
- HIT vs CBUS Comparison
HIT vs CBUS Comparison
Compare HIT & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIT | CBUS |
|---|---|---|
| Founded | 1964 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.4M | 69.9M |
| IPO Year | 2024 | 2017 |
Fundamental Metrics
Financial Performance| Metric | HIT | CBUS |
|---|---|---|
| Price | $1.60 | $1.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.50 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 696.0K | 177.8K |
| Earning Date | 02-16-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $30,723,490.00 | $3,794,000.00 |
| Revenue This Year | $67.75 | N/A |
| Revenue Next Year | $29.82 | $109.96 |
| P/E Ratio | $80.37 | ★ N/A |
| Revenue Growth | ★ 55.15 | N/A |
| 52 Week Low | $0.51 | $1.09 |
| 52 Week High | $7.59 | $3.40 |
Technical Indicators
Market Signals| Indicator | HIT | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 51.64 | 57.34 |
| Support Level | $1.24 | $1.59 |
| Resistance Level | $1.90 | $1.80 |
| Average True Range (ATR) | 0.17 | 0.14 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 64.94 | 65.15 |
Price Performance
Historical ComparisonAbout HIT Health In Tech Inc.
Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.